Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering ...

The primary completion date of the PIK3CA wild-type cohort of the VIKTORIA-1 Phase 3 trial is expected in June 2025 and a ...

Biomed Israel 2025: the 23rd National Life Science & Technology Week is taking place in Tel Aviv, between 20 and 22 May.

The latest Top Ten uses of generative AI were announced. At #1 is therapy/companionship. Here's an AI insider look at all of ...

From Jim Harbaugh to Deion Sanders, coaches in all sports use videos from the animal kingdom to relay a specific theme or ...

According to AI, these are the 10 most popular apps, along with their standout features, benefits, and the reasons they ...

From narration to accessibility, AI voice tools are changing how we work. Here's what to try — and what to know.

Whether you’re working in a startup, academic lab, or biopharma R&D team, this eBook offers a window into what’s working now and what’s possible next.

The Biotechnology Program has also expanded its STEM outreach efforts to include a summer internship program for high school ...

Deb Hart; Head, Investor Relations; Maravai LifeSciences Holdings Inc. William Martin; Chief Executive Officer; Maravai LifeSciences Holdings Inc. Kevin Herde; Chief ...

LONDON and NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical-stage genetic medicines company, today announced financial and operational ...

Q2 2025 Earnings Conference Call May 12, 2025 4:30 PM ET. Company Participants. Vincent Anzalone - Vice President of Investor Relatio ...